Author

Michael T. Mattingly

Observed names: M T Mattingly, M. Mattingly, M. T. Mattingly

Institution: University of Kentucky

Observed institutions: Creighton University, Mayo Clinic, University of Kentucky, Pfizer (United Kingdom)

OpenAlex ID: A5078847356

Presence of C-type natriuretic peptide in human kidney and urine

1994 · Michael T. Mattingly, Roland R. Brandt, et al. · Kidney International · 73

Angiotensin converting enzyme inhibition modulates endogenous endothelin in chronic canine thoracic inferior vena caval constriction.

1996 · A L Clavell, M T Mattingly, et al. · Journal of Clinical Investigation · 68

Neutral Endopeptidase Regulates C-Type Natriuretic Peptide Metabolism But Does Not Potentiate Its Bioactivity In Vivo

1997 · Roland R. Brandt, Michael T. Mattingly, et al. · Hypertension · 29

Erratum: Presence of C-type natriuretic peptide in human kidney and urine (Kidney International 46 (1994) (744-747))

1996 · M. T. Mattingly, Ragnar Brandt, et al. · Kidney International · 16

Presence and secretion of atrial natriuretic peptide from cultured human aortic endothelial cells

1995 · R. R. Brandt, D. M. Heublein, et al. · American Journal of Physiology-Heart and Circulatory Physiology · 14

Decreased Cell Membrane Magnesium in Some Essential Hypertension Patients

1991 · M. T. Mattingly, W. A. Brzezinski, et al. · Clinical and Experimental Hypertension · 5

The use of bevacizumab and cytotoxic and consolidation chemotherapy for the upfront treatment of advanced ovarian cancer: Practice patterns among medical and gynecologic oncology SGO members

2011 · J. Elder, M. Mattingly, et al. · Gynecologic Oncology

Works count: 7

Citation count: 205

H-index: 5

I10-index: 5